Secondary prevention of cervical cancer: a modern approach to diagnosis

According to WHO, cervical cancer is the fourth most common type of cancer among women in the world, in 2020 the number of new cases of the disease reached 604,000. Among women of reproductive age, cervical cancer is the second most com[1]mon type of cancer and the second cause of cancer death in th...

Full description

Saved in:
Bibliographic Details
Main Author: T. V. Klinyshkova
Format: Article
Language:Russian
Published: Open Systems Publication 2023-01-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/1000
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850065287031816192
author T. V. Klinyshkova
author_facet T. V. Klinyshkova
author_sort T. V. Klinyshkova
collection DOAJ
description According to WHO, cervical cancer is the fourth most common type of cancer among women in the world, in 2020 the number of new cases of the disease reached 604,000. Among women of reproductive age, cervical cancer is the second most com[1]mon type of cancer and the second cause of cancer death in the world. In the Russian Federation, the incidence of cervical cancer in recent years has been in the second position after uterine body cancer in the structure of genital cancers in the country. The problem of increasing incidence of cervical cancer requires the improvement of cervical screening. The last decade is characterized by the emergence of new highly informative methods for diagnosing precancer and the active introduction of modern approaches into practice in many countries. In the WHO Global Strategy to Accelerate the Elimination of cervical cancer as a public health problem, cervical screening is given priority. Modern cervical screening includes switching to primary human papillomavirus (HPV) screening or a соtesting followed by a triage in case of human papillomavirus detection. An overview and analysis of current data on this problem over the past decade is presented. The issues of evidence of the informativeness of traditional cytological screening, liquid cytology, HPV screening, cotesting, triage strategies of HPV-positive women, human papillomavirus screening interval are discussed. The immunocytochemical method of double staining p16/Ki67 is proposed for triage HPV-positive women, as more informative than cytological for the detection of CIN2+/CIN3+, an assessment of the risk stratification of precancerous using this method was carried out. Along with the expansion of human papillomavirus vaccination, increasing the level of cervical screening and coverage of the female population will help to reduce the morbidity and mortality associated with cervical cancer.
format Article
id doaj-art-645d98f7dc84494e93fca89c118bce27
institution DOAJ
issn 1560-5175
2687-1181
language Russian
publishDate 2023-01-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-645d98f7dc84494e93fca89c118bce272025-08-20T02:49:02ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812023-01-01012263110.51793/OS.2022.25.12.004995Secondary prevention of cervical cancer: a modern approach to diagnosisT. V. Klinyshkova0Federal State Budgetary Educational Institution of Higher Education Omsk State Medical University of the Ministry of Health of the Russian FederationAccording to WHO, cervical cancer is the fourth most common type of cancer among women in the world, in 2020 the number of new cases of the disease reached 604,000. Among women of reproductive age, cervical cancer is the second most com[1]mon type of cancer and the second cause of cancer death in the world. In the Russian Federation, the incidence of cervical cancer in recent years has been in the second position after uterine body cancer in the structure of genital cancers in the country. The problem of increasing incidence of cervical cancer requires the improvement of cervical screening. The last decade is characterized by the emergence of new highly informative methods for diagnosing precancer and the active introduction of modern approaches into practice in many countries. In the WHO Global Strategy to Accelerate the Elimination of cervical cancer as a public health problem, cervical screening is given priority. Modern cervical screening includes switching to primary human papillomavirus (HPV) screening or a соtesting followed by a triage in case of human papillomavirus detection. An overview and analysis of current data on this problem over the past decade is presented. The issues of evidence of the informativeness of traditional cytological screening, liquid cytology, HPV screening, cotesting, triage strategies of HPV-positive women, human papillomavirus screening interval are discussed. The immunocytochemical method of double staining p16/Ki67 is proposed for triage HPV-positive women, as more informative than cytological for the detection of CIN2+/CIN3+, an assessment of the risk stratification of precancerous using this method was carried out. Along with the expansion of human papillomavirus vaccination, increasing the level of cervical screening and coverage of the female population will help to reduce the morbidity and mortality associated with cervical cancer.https://journal.lvrach.ru/jour/article/view/1000cervical cancer screeninghuman papillomavirus testingco-testingtriagep16/ki67 dual-staining
spellingShingle T. V. Klinyshkova
Secondary prevention of cervical cancer: a modern approach to diagnosis
Лечащий Врач
cervical cancer screening
human papillomavirus testing
co-testing
triage
p16/ki67 dual-staining
title Secondary prevention of cervical cancer: a modern approach to diagnosis
title_full Secondary prevention of cervical cancer: a modern approach to diagnosis
title_fullStr Secondary prevention of cervical cancer: a modern approach to diagnosis
title_full_unstemmed Secondary prevention of cervical cancer: a modern approach to diagnosis
title_short Secondary prevention of cervical cancer: a modern approach to diagnosis
title_sort secondary prevention of cervical cancer a modern approach to diagnosis
topic cervical cancer screening
human papillomavirus testing
co-testing
triage
p16/ki67 dual-staining
url https://journal.lvrach.ru/jour/article/view/1000
work_keys_str_mv AT tvklinyshkova secondarypreventionofcervicalcanceramodernapproachtodiagnosis